The central Chinese government has pledged to increase R&D spending 12.4% this year to CNY 228.5 billion ($36.1 billion). Spending for basic research will rise 10.1% to CNY 32.5 billion. In addition, funding for new technologies for agriculture will rise 53% to CNY 10.1 billion. The increases are the latest in China’s continuing growth in […]
According to a new working paper from UnitedHealth Group, genetic tests are available for 2,500 conditions. There are between 1,000 and 1,300 genetic tests, but only 400 have evidence-based guidelines. Seven manufacturers lead the market and 1,000 US labs offer such tests. UnitedHealth estimates that in 2010 it spent $500 million on genetic and molecular […]
In his 2013 budget, President Obama proposed total federal R&D spending of $140.8 billion; a 1.4% increase over 2012 enacted levels. Basic and applied research funding would grow 1.5% and 5.0% to $30.6 billion and $33.4 billion, respectively. Development funding would decrease less than 1% to $74.1 billion. The proposal includes a 10.9% R&D boost […]
The FDA approved 34 new molecular entities in its fiscal year ending September 30, 2011; the highest number since 2007. Eleven biologics license applications were approved. Biologic approvals included a high number of orphan indicators and first-time approvals for companies. Seattle Genetics’ Adcetris for treating Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma was approved. […]
Fourth-quarter 2011 IBO Life Science Index sales grew 5.2%, 5.0% excluding currency, to $3,599.71 million. Operating profit expanded 4.4% to $829.93 million, but operating margin slipped 30 basis points to 22.7% of revenues. For 2011, Life Science Index sales grew 7.0%, 5.5% on a currency-neutral basis, to $13,047.60 million. Operating profit rose 5.5% to $2,820.89 […]
Washington, DC 2/29/12—Bruker reported in its 10K SEC filing that it has completed its internal investigation of improper payments by Bruker Optics employees to Chinese government-owned enterprises (see IBO 8/15/11). The company found evidence that improper payments were made that did not comply with its policies and standards of conduct. As a result, Bruker terminated […]
Abbott Park, IL 3/2/12—STARLIMS Technologies, an Abbott business, has purchased several distribution partners, including French distributor Varilab, two Spanish businesses, a Dutch company, and its Israeli distribution partner. The company has also established STARLIMS Germany to provide direct support for German and Swiss customers. “With these acquisitions, we now have more than 100 experienced LIMS […]
Houston, TX 3/6/12—PAC, a Roper Industries–owned supplier of analytical and online process instrumentation, has acquired Cambridge Viscosity for an undisclosed amount. Cambridge Viscosity provides small-sample fluid viscosity measurement systems utilizing electromagnetic-based sensor technology. “With over 25 years of experience, Cambridge Viscosity has served the oil and gas, paint, ink and coating, pharmaceutical and chemical industries […]
Larchmont, NY 3/1/12; San Diego, CA 3/1/12—A Delaware District Court jury has found that certain Illumina sample preparation and cluster generation kits infringe LadaTech’s US Patent No. 6,107,023 (see IBO 4/30/10). According to LadaTech, the patent covers the DNA amplification process required for sample preparation and cluster station amplification steps. The jury also found the […]
London, UK 3/5/12—Abcam, a supplier of protein research tools, has agreed to acquire Epitomics for $155 million (net Epitomics’ $15 million in cash) in cash and stock. Epitomics provides rabbit monoclonal antibodies (RabMAbs) and has three units: Reagents, which develops and distributes antibodies for research applications; custom antibodies for research and diagnostic applications; and IVD […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
